The Top EDC and Clinical Trial Platforms in 2026
A practical guide to the leading EDC and eClinical platforms in 2026: the enterprise incumbents, the agile challengers, and how to pick the right system for your trial.
A practical guide to the leading EDC and eClinical platforms in 2026: the enterprise incumbents, the agile challengers, and how to pick the right system for your trial.
Rare disease trials face tiny patient populations and scattered sites. Here are the CROs best equipped for rare disease research and how to choose the right partner.
A guide to the leading bioprocessing suppliers: who supplies the bioreactors, single-use systems, filtration and chromatography that every biologics plant depends on.
A guide to the leading lab automation and liquid handling companies in 2026, from Hamilton and Tecan to Opentrons, and how to choose the right system for your lab.
The leading biologics CDMOs in 2026: who has the capacity, who leads in antibodies and ADCs, how the reshoring wave is reshaping the market, and how to choose.
A guide to the leading real world evidence and real world data companies, what each offers, and how biotechs use RWE for regulators, payers and development.
A guide to the leading companion diagnostics companies, how CDx partnerships work with pharma, and how to choose a partner for your targeted therapy program.
A guide to the leading sequencing and single-cell technology companies, how the competitive landscape has shifted, and how to choose a platform for your research.
Oncology trials are the hardest to run. Here are the CROs with the deepest oncology expertise, what distinguishes them, and how to choose the right partner for your cancer trial.
A guide to the leading small molecule CDMOs in 2026, what each is known for, how the market is shifting, and how to pick the right API and drug product partner.